1. Low Pretransplantation Mannose-Binding Lectin Levels Predict Superior Patient and Graft Survival after Simultaneous Pancreas-Kidney Transplantation
- Author
-
Stefan P Berger, Marko J.K. Mallat, Friedo W. Dekker, Ilias I.N. Doxiadis, Mohamed R. Daha, Cees van Kooten, Johan W. de Fijter, Alexander F. Schaapherder, and Anja Roos
- Subjects
Adult ,Male ,Nephrology ,medicine.medical_specialty ,medicine.medical_treatment ,chemical and pharmacologic phenomena ,Kaplan-Meier Estimate ,Pancreas transplantation ,Mannose-Binding Lectin ,Organ transplantation ,Predictive Value of Tests ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Preoperative Care ,medicine ,Humans ,Diabetic Nephropathies ,Complement Activation ,Kidney transplantation ,Mannan-binding lectin ,business.industry ,Graft Survival ,General Medicine ,Middle Aged ,bacterial infections and mycoses ,medicine.disease ,Kidney Transplantation ,Transplantation ,Lectin pathway ,Immunology ,Kidney Failure, Chronic ,Female ,Pancreas Transplantation ,business - Abstract
Simultaneous pancreas-kidney transplantation (SPKT) is the treatment of choice for patients with type 1 diabetes and renal failure. However, this procedure is characterized by a high rate of postoperative infections, acute rejection episodes, and cardiovascular mortality. The lectin pathway of complement activation contributes to cardiovascular disease in diabetes and may play an important role in inflammatory damage after organ transplantation. This study therefore sought to determine how mannose-binding lectin (MBL), a major recognition molecule of the lectin pathway of complement activation, influences outcome after SPKT. MBL serum levels were determined in 99 and MBL genotypes in 97 consecutive patients who received an SPKT from 1990 through 2000 and related to patient and graft survival. At 12 yr, cumulative death-censored kidney graft survival was 87.5% in patients with an MBL level400 ng/ml and 74.8% in the group with MBL levels400 ng/ml (P = 0.021). Pancreas graft survival was significantly better in patients with low MBL levels (P = 0.016). MBL levels400 ng/ml were associated with a hazard ratio of 6.28 for patient death (95% confidence interval 1.8 to 20.3; P = 0.003). Accordingly, survival was significantly better in recipients with MBL gene polymorphisms associated with low MBL levels. These findings identify MBL as a potential risk factor for graft and patient survival in SPKT. It is hypothesized that MBL contributes to the pathogenesis of inflammation-induced vascular damage both in the transplanted organs and in the recipient's native blood vessels.
- Published
- 2007